[Possibilities and limits of treatment of aggressive behavior in patients with mental retardation with risperidone]. 2002

F Hässler, and J Buchmann, and S Bohne
Klinik für Kinder- und Jugendneuropsychiatrie/-psychotherapie, Universität Rostock.

Despite definite indication for psychopharmacologic intervention, severe and persistent symptoms of aggressive and self-injurious behaviour still remain a therapeutic challenge. As recent research has demonstrated, not only the dopaminergic and serotonergic but also the endogenous opiate system plays a role in the pathogenesis of self-injurious behaviour. Nevertheless, the efficacy of classical neuroleptics as well as opiate antagonists is questioned. In open and controlled studies, the administration of the atypical neuroleptic risperidone (a serotonin 2A-dopamine D2 antagonist) was associated with a long-term effect in reducing self-injuries. In our clinical trial, 20 mentally retarded adults presenting with severe self-injurious and aggressive behaviour were administered risperidone over a follow-up period of 35 months. Clinical efficacy was measured with the Disability Assessment Schedule (DAS), conducted in a home for people with mental retardation. In 17 patients, a significant reduction in self-injurious behaviour is shown. Besides, there was a significant overall clinical improvement in behaviour.

UI MeSH Term Description Entries
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000374 Aggression Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism. Aggressions
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major
D016728 Self-Injurious Behavior Behavior in which persons hurt or harm themselves without the motive of suicide or of sexual deviation. Intentional Self Harm,Intentional Self Injury,Self Harm,Self-Destructive Behavior,Deliberate Self-Harm,Non-Suicidal Self Injury,Nonsuicidal Self Injury,Self-Injury,Behavior, Self-Destructive,Behavior, Self-Injurious,Deliberate Self Harm,Harm, Self,Intentional Self Injuries,Non Suicidal Self Injury,Non-Suicidal Self Injuries,Nonsuicidal Self Injuries,Self Destructive Behavior,Self Harm, Intentional,Self Injurious Behavior,Self Injury,Self Injury, Intentional,Self Injury, Non-Suicidal,Self Injury, Nonsuicidal,Self-Destructive Behaviors,Self-Harm, Deliberate,Self-Injurious Behaviors

Related Publications

F Hässler, and J Buchmann, and S Bohne
December 1990, American family physician,
F Hässler, and J Buchmann, and S Bohne
June 1998, Journal of autism and developmental disorders,
F Hässler, and J Buchmann, and S Bohne
December 2000, Journal of clinical psychopharmacology,
F Hässler, and J Buchmann, and S Bohne
January 2000, Actas espanolas de psiquiatria,
F Hässler, and J Buchmann, and S Bohne
October 2014, Journal of clinical psychopharmacology,
F Hässler, and J Buchmann, and S Bohne
November 1996, American journal of mental retardation : AJMR,
F Hässler, and J Buchmann, and S Bohne
May 1995, Pharmacopsychiatry,
F Hässler, and J Buchmann, and S Bohne
February 2001, The Journal of clinical psychiatry,
F Hässler, and J Buchmann, and S Bohne
January 1996, Psychopharmacology bulletin,
Copied contents to your clipboard!